HOME >> BIOLOGY >> NEWS
Loss Of Tumor Suppressor Gene Triggers Colon Cancer

September 3,1998—Researchers have found the first connection between the loss of a tumor suppressor gene and activation of a cancer-promoting oncogene, a scenario thought to be prevalent in the initiation of many cancers but which has never been proven.

The newfound link also helps to explain the genesis of most cases of colon cancer, the second leading cause of cancer deaths in the United States.

The scientists found that mutated APC genes, regarded as one of the body's master brakes on cell growth, switch on c-MYC, a gene long associated with cancers of various sorts in both animals and humans.

"This connection is fascinating and we hope it leads to further understanding of this pathway," says Bert Vogelstein, an HHMI investigator at The Johns Hopkins Oncology Center. The report by Vogelstein and Johns Hopkins colleagues, Kenneth Kinzler and HHMI associate Tong-Chuan He, appears in the September 4, 1998, issue of the journal Science.

For Vogelstein, who has studied the genetic basis of colon cancer for nearly 20 years, "this ends one chapter of the APC story," but begins many more. "Master genes such as p53, another tumor suppressor, or APC usually don't work on just one pathway. So c-MYC is probably not the only gene whose expression is controlled by APC. We are working to find the others," he said.

The discovery also offers hope of finding new ways to treat colon cancer. Knowing that the c-MYC oncogene is one final link in the colon cancer chain "brings up an obvious and potentially powerful way to disrupt that interaction," Vogelstein says. Vogelstein's team plans to begin screening compounds that can block expression of the c-MYC oncogene through interference with the transcription factors regulated by APC.

In 1991, investigators including the Vogelstein-Kinzler team first identified
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
(301) 215-8858
Howard Hughes Medical Institute
4-Sep-1998


Page: 1 2 3

Related biology news :

1. Tumor cell-specific therapy shows preclinical promise
2. Tumor cells made more sensitive to radiation by blocking a key cellular molecule
3. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
4. Dietary Lutein Inhibits Mammary Tumor Growth And Normalizes Immune Balance In Tumor-Bearing Mice
5. Tumor Oxygen Level And Blood Flow Fluctuate, Duke Scientists Discover
6. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
7. Compounds From Fruits, Vegetables And Grains Slow The Growth Of Human Tumor Cells
8. New Cell Isolation Method Will Aid In Studying Tumor Development
9. Wistar Institute To Host 3rd International Conference On Molecular And Clinical Genetics Of Childhood Renal Tumors And The Mitchell Ross Symposium
10. Scientists Study Proteins Role In Tumor Development In Fish
11. Fly Tumor Points Way To New Understanding Of Cancer Development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/30/2020)... Ontario (PRWEB) , ... January 30, 2020 , ... ... with an eye on the Canadian market, is pleased to announce that the company ... of growth since the company launched in 2017. , “We are so thrilled ...
(Date:1/29/2020)... ... January 29, 2020 , ... ... vitro toxicology testing solutions, has announced a record earnings year for 2019. With ... showed more than a twenty percent increase in revenue and a thirty percent ...
(Date:1/28/2020)... CAMBRIDGE, Mass. (PRWEB) , ... January 28, 2020 ... ... problems for life sciences companies and government agencies, announced that the firm has ... in the country. Tunnell’s Cambridge office will be in the Cambridge Innovation Center ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... Genedata, ... the release of Genedata Expressionist ® 13.5 at the 2020 WCBP ... Methods (MAM) for characterizing and monitoring the quality of biopharmaceuticals throughout their ...
(Date:1/24/2020)... ... January 24, 2020 , ... The ... in biotechnology, diagnostics, therapeutics, laboratory and clinical services during the first two decades ... the world. And as Slone Partners celebrates its 20th anniversary this ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... precision of Genome editing. The partners have agreed to co-develop and market a ... research, agricultural, and pre-clinical programs. Over the longer-term, the parties aim to develop ...
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet Products ... specific properties for use in harsh environments inside or outside of the human ... three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or ...
Breaking Biology Technology:
Cached News: